These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 12809566)

  • 21. Influence of trial duration on the bias of the estimated treatment effect in clinical trials when individual heterogeneity is ignored.
    Cécilia-Joseph E; Auvert B; Broët P; Moreau T
    Biom J; 2015 May; 57(3):371-83. PubMed ID: 25597640
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints.
    Harbord RM; Egger M; Sterne JA
    Stat Med; 2006 Oct; 25(20):3443-57. PubMed ID: 16345038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The SIMEX approach to measurement error correction in meta-analysis with baseline risk as covariate.
    Guolo A
    Stat Med; 2014 May; 33(12):2062-76. PubMed ID: 24339017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events?
    Als-Nielsen B; Chen W; Gluud C; Kjaergard LL
    JAMA; 2003 Aug; 290(7):921-8. PubMed ID: 12928469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of allocation concealment on conclusions drawn from meta-analyses of randomized trials.
    Pildal J; Hróbjartsson A; Jørgensen KJ; Hilden J; Altman DG; Gøtzsche PC
    Int J Epidemiol; 2007 Aug; 36(4):847-57. PubMed ID: 17517809
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between analytic strategy and estimates of treatment outcomes in meta-analyses.
    Dechartres A; Altman DG; Trinquart L; Boutron I; Ravaud P
    JAMA; 2014 Aug; 312(6):623-30. PubMed ID: 25117131
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A critical review of methods for the assessment of patient-level interactions in individual participant data meta-analysis of randomized trials, and guidance for practitioners.
    Fisher DJ; Copas AJ; Tierney JF; Parmar MK
    J Clin Epidemiol; 2011 Sep; 64(9):949-67. PubMed ID: 21411280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Meta-analyses involving cluster randomization trials: a review of published literature in health care.
    Laopaiboon M
    Stat Methods Med Res; 2003 Dec; 12(6):515-30. PubMed ID: 14653354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subpopulation Treatment Effect Pattern Plot (STEPP) analysis for continuous, binary, and count outcomes.
    Yip WK; Bonetti M; Cole BF; Barcella W; Wang XV; Lazar A; Gelber RD
    Clin Trials; 2016 Aug; 13(4):382-90. PubMed ID: 27094489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Accounting for uncertainty due to 'last observation carried forward' outcome imputation in a meta-analysis model.
    Dimitrakopoulou V; Efthimiou O; Leucht S; Salanti G
    Stat Med; 2015 Feb; 34(5):742-52. PubMed ID: 25492741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A bivariate approach to meta-analysis.
    Van Houwelingen HC; Zwinderman KH; Stijnen T
    Stat Med; 1993 Dec; 12(24):2273-84. PubMed ID: 7907813
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between unreported outcomes and effect size estimates in Cochrane meta-analyses.
    Furukawa TA; Watanabe N; Omori IM; Montori VM; Guyatt GH
    JAMA; 2007 Feb; 297(5):468-70. PubMed ID: 17284696
    [No Abstract]   [Full Text] [Related]  

  • 33. Issues in the selection of a summary statistic for meta-analysis of clinical trials with binary outcomes.
    Deeks JJ
    Stat Med; 2002 Jun; 21(11):1575-600. PubMed ID: 12111921
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessing subgroup effects with binary data: can the use of different effect measures lead to different conclusions?
    White IR; Elbourne D
    BMC Med Res Methodol; 2005 Apr; 5():15. PubMed ID: 15862124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Odds ratio for 2 × 2 tables: Mantel-Haenszel estimator, profile likelihood, and presence of surrogate responses.
    Banerjee B; Biswas A
    J Biopharm Stat; 2014; 24(3):649-59. PubMed ID: 24697719
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discrepancies between meta-analyses and subsequent large randomized, controlled trials.
    LeLorier J; Grégoire G; Benhaddad A; Lapierre J; Derderian F
    N Engl J Med; 1997 Aug; 337(8):536-42. PubMed ID: 9262498
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Graphical methods for detecting bias in meta-analysis.
    Ferrer RL
    Fam Med; 1998 Sep; 30(8):579-83. PubMed ID: 9773289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of odds ratio or relative risk to measure a treatment effect in clinical trials with multiple correlated binary outcomes: data from the NINDS t-PA stroke trial.
    Lu M; Tilley BC;
    Stat Med; 2001 Jul; 20(13):1891-901. PubMed ID: 11427947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The transitive fallacy for randomized trials: if A bests B and B bests C in separate trials, is A better than C?
    Baker SG; Kramer BS
    BMC Med Res Methodol; 2002 Nov; 2():13. PubMed ID: 12429069
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessing the impact of attrition in randomized controlled trials.
    Hewitt CE; Kumaravel B; Dumville JC; Torgerson DJ;
    J Clin Epidemiol; 2010 Nov; 63(11):1264-70. PubMed ID: 20573482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.